Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future

ACS Infectious Diseases
Paul W SmithOla Epemolu

Abstract

β-Lactams represent perhaps the most important class of antibiotics yet discovered. However, despite many years of active research, none of the currently approved drugs in this class combine oral activity with long duration of action. Recent developments suggest that new β-lactam antibiotics with such a profile would have utility in the treatment of tuberculosis. Consequently, the historical β-lactam pharmacokinetic data have been compiled and analyzed to identify possible directions and drug discovery strategies aimed toward new β-lactam antibiotics with this profile.

References

Sep 1, 1992·Antimicrobial Agents and Chemotherapy·A KuriharaY Kawahara
Dec 1, 1991·The Journal of Pharmacy and Pharmacology·M SugawaraJ Uchino
Dec 1, 1986·The Journal of Antimicrobial Chemotherapy·G L Drusano
Jun 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·Y SawadaT Iga
Feb 1, 1994·Thorax·D Honeybourne
Jan 1, 1993·Infection·J Heesemann
Jun 13, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H F ChambersP C Hopewell
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·A HoffmanM Friedman
Oct 24, 2002·British Journal of Clinical Pharmacology·Hiroshi SaitohKatsumi Miyazaki
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Markus MüllerHartmut Derendorf
Jun 4, 2004·Journal of Pharmaceutical Sciences·Toshihiro WajimaTakayoshi Oguma
Jul 3, 2004·European Journal of Drug Metabolism and Pharmacokinetics·Gary W CaldwellWilliam Hageman
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·David E NixEmily C Ferguson
Oct 30, 2004·Journal of Pharmaceutical Sciences·Suchada WanchanaMitsuru Hashida
Apr 18, 2008·The Journal of Pharmacy and Pharmacology·Matthias BrandschEva Bosse-Doenecke
Apr 23, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·R Scott ObachNigel J Waters
Jun 13, 2009·Expert Opinion on Drug Metabolism & Toxicology·Matthias Brandsch
Jan 1, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Kok-Fai KongKalai Mathee
Apr 8, 2010·Current Computer-aided Drug Design·David W FoleyDavid Meredith
May 4, 2011·Antimicrobial Agents and Chemotherapy·Markus A ZeitlingerUrsula Theuretzbacher
Oct 4, 2011·Applied Microbiology and Biotechnology·Nelson Kardos, Arnold L Demain
Dec 6, 2011·Archives of Pharmacal Research·Hee Eun Kang, Myung Gull Lee
May 23, 2012·Antimicrobial Agents and Chemotherapy·Vincent DubéeMichel Arthur
Oct 27, 2012·Chemical Society Reviews·David T ManallackDavid K Chalmers
Oct 31, 2012·Expert Review of Anti-infective Therapy·Sebastian G Kurz, Robert A Bonomo
Jan 26, 2013·Annals of the New York Academy of Sciences·George H Talbot
Apr 17, 2013·Clinical Pharmacology and Therapeutics·K M HillgrenUNKNOWN International Transporter Consortium
Sep 7, 2013·Current Opinion in Pharmacology·Matthias Brandsch

❮ Previous
Next ❯

Methods Mentioned

BETA
PCA

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.